Yan-peng Xu
State Key Laboratory Of Pathogen And Biosecurity
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
MicroRNA-124-targeted recombinant Zika virus: a dual-functional and safe candidate for vaccination and oncolytic virotherapy.
Journal: Journal of virology
Published: May 15, 2026
Rational design of a DNA-launched live attenuated vaccine against human enterovirus 71.
Journal: Virologica Sinica
Published: September 21, 2024
Manganese Mineralization of Pathogenic Viruses as a Universal Vaccine Platform.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 04, 2023
Pathogenicity and Structural Basis of Zika Variants with Glycan Loop Deletions in the Envelope Protein.
Journal: Journal of virology
Published: November 15, 2022
Changes in endemic patterns of respiratory syncytial virus infection in pediatric patients under the pressure of nonpharmaceutical interventions for COVID-19 in Beijing, China.
Journal: Journal of medical virology
Published: October 08, 2022
Human bocavirus 1 and 2 genotype-specific antibodies for rapid antigen testing in pediatric patients with acute respiratory infections.
Journal: World journal of pediatrics : WJP
Published: July 11, 2022
Characterization of m6 A modifications in the contemporary Zika virus genome and host cellular transcripts.
Journal: Journal of medical virology
Published: March 24, 2022
A highly immunogenic live-attenuated vaccine candidate prevents SARS-CoV-2 infection and transmission in hamsters.
Journal: Innovation (Cambridge (Mass.))
Published: November 11, 2021
Last Updated: 09/26/2026